UBIQUITX INC
UBIQUITX INC is a federal contractor, registered under UEI LRA7LGJCZP15 and CAGE code 8W3S4. It has been awarded $1,634,696 in federal contracts. Primary work spans Unknown NAICS and Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Top awarding agencies include Department Of Health And Human Services and National Science Foundation.
Contact Information
Registration and classification details
Registration
UEI Code
LRA7LGJCZP15CAGE Code
8W3S4Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
UBIQUITX INC specializes in advanced research and development focused on targeted protein degradation technologies, with demonstrated expertise in designing novel platforms for the selective elimination of oncogenic fusion proteins. Their work centers on chemical biology and molecular therapeutics, ...
UBIQUITX INC specializes in advanced research and development focused on targeted protein degradation technologies, with demonstrated expertise in designing novel platforms for the selective elimination of oncogenic fusion proteins. Their work centers on chemical biology and molecular therapeutics, leveraging proprietary platforms to engineer precision degraders that disrupt disease-causing proteins implicated in cancer. This places them at the intersection of medicinal chemistry, structural biology, and translational oncology, with a strong emphasis on developing small-molecule modulators that hijack the ubiquitin-proteasome system. Their technical differentiation lies in the design of bifunctional molecules capable of inducing targeted protein degradation—a cutting-edge approach distinct from traditional inhibition strategies. The company has delivered research services to the Department of Health and Human Services, specifically advancing therapeutic platforms aimed at undruggable cancer targets. This engagement reflects a focus on high-impact biomedical innovation within HHS’s research and development ecosystem, particularly under agencies such as the National Institutes of Health. Their work supports the agency’s mission to translate laboratory discoveries into novel therapeutic candidates with clinical potential. UBIQUITX INC operates primarily under NAICS 541715, indicating a dedicated focus on physical and life sciences R&D excluding nanotechnology and biotechnology. This positions them as a specialized research contractor in molecular therapeutics, serving the biopharmaceutical innovation pipeline rather than broad biological or diagnostic applications. Their market niche is in precision oncology R&D, targeting previously inaccessible oncogenic drivers through innovative chemical biology. As a small business structured as a 2L entity based in New York, NY, UBIQUITX INC operates with agility in the federal R&D landscape. While they currently hold no formal government certifications, their technical focus and HHS engagement demonstrate alignment with high-priority national health research objectives. Their geographic presence in a major biomedical hub enhances access to academic and clinical partnerships critical to advancing their platform technology.
Key Performance Metrics
Awards Count
5
All time
Active
2
Currently performing
Completed
3
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with UBIQUITX INC
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for UBIQUITX INC
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
